Global Retirement Partners’s Vir Biotechnology VIR Stock Holding History

Global Retirement Partners’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$6.03K	Sell	1,000 -500	-33%	-$2.98K	﹤0.01%	3371
2025 Q3	$8.56K	Buy	+1,500	New	+$7.67K	﹤0.01%	2757
2023 Q3	–	Sell	-24	Closed	-$589	–	3342
2023 Q2	$589	Hold	24	–	–	﹤0.01%	2917
2023 Q1	$609	Hold	24	–	–	﹤0.01%	2879
2022 Q4	$607	Hold	24	–	–	﹤0.01%	2713
2022 Q3	$1K	Sell	24 -33	-58%	-$839	﹤0.01%	2610
2022 Q2	$1K	Buy	57 +10	+21%	+$233	﹤0.01%	2591
2022 Q1	$1K	Buy	+47	New	+$1.39K	﹤0.01%	2546

Other funds holding VIR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Global Retirement Partners's VIR Position: Q4 2025 in Review

Global Retirement Partners reduced its Vir Biotechnology (VIR) stake by 33% in Q4 2025, selling an estimated $2.98K and leaving 1,000 shares worth $6.03K. The position accounts for ﹤0.01% of the portfolio, ranked #3371.

Global Retirement Partners first reported a position in VIR in Q1 2022 and has held it in 8 quarters since. The position peaked at $8.56K in Q3 2025. 218 funds tracked by Wall St. Rank hold VIR as of Q4 2025.

Global Retirement Partners held 1,000 shares of Vir Biotechnology worth $6.03K as of Q4 2025.
Global Retirement Partners sold 500 Vir Biotechnology shares in Q4 2025, an estimated $2.98K.
Vir Biotechnology made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3371 holding.
Global Retirement Partners first reported a position in Vir Biotechnology in Q1 2022 and has held it in 8 quarters since.
Global Retirement Partners's Vir Biotechnology position peaked at $8.56K in Q3 2025.
218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.